ACTIVE SUBSTANCE / INN

AUTOLOGOUS CARTILAGE-DERIVED ARTICULAR CHONDROCYTES, IN-VITRO EXPANDED

Brand name(s): Jelrix

EMA LISTED

APPLICATION WITHDRAWN

Knee Injuries;Cartilage Diseases;Knee Joint

ACTIVE SUBSTANCE

Autologous Cartilage-Derived Articular Chondrocytes, In-Vitro Expanded

REGULATORS

EMA

SPONSORS / MAH

TETEC Tissue Engineering Technologies AG

TOTAL APPLICATIONS

EMA AUTHORISATIONS

PRODUCT NAME	HOLDER	STATUS	DATE	INDICATION
Jelrix	TETEC Tissue Engineering Technologies AG	Application withdrawn		Knee Injuries;Cartilage Diseases;Knee Joint

FULL INTELLIGENCE ON AUTOLOGOUS CARTILAGE-DERIVED ARTICULAR CHONDROCYTES, IN-VITRO EXPANDED